Evaluating the effectiveness of the NHS Health Check programme in South England: a quasi-randomised controlled trial

Objective To evaluate uptake, risk factor detection and management from the National Health Service (NHS) Health Check (HC). Design This is a quasi-randomised controlled trial where participants were allocated to five cohorts based on birth year. Four cohorts were invited for an NHS HC between April 2011 and March 2015. Setting 151 general practices in Hampshire, England, UK. Participants 366 005 participants born 1 April 1940–31 March 1976 eligible for an NHS HC. Intervention NHS HC invitation. Main outcome measures HC attendance and absolute percentage changes and ORs of (1) detecting cardiovascular disease (CVD) 10-year risk >10% and >20%, smokers, and total cholesterol (TC) >5.5 mmol/L and >7.5 mmol/L; (2) diagnosing hypertension, type 2 diabetes mellitus, chronic kidney disease (CKD) and atrial fibrillation (AF); and (3) new interventions with statins, antihypertensives, antiglycaemics and nicotine replacement therapy (NRT). Results HC attendance rose from 12% to 30% between 2011/2012 and 2014/2015 (p 10% (2.0%–3.6, p 20% (0.1%–0.6%, p 5.5 mmol/L (4.1%–7.0%, p 7.5 mmol/L (0.3%–0.4% p 10% (OR 8.01, 95% CI 7.34 to 8.73) and >20% (5.86, 4.83 to 7.10), TC >5.5 mmol/L (3.72, 3.57 to 3.89) and >7.5 mmol/L (2.89, 2.46 to 3.38), and diagnoses of hypertension (1.33, 1.20 to 1.47) and diabetes (1.34, 1.12 to 1.61). OR of CVD risk >10% plus statin and >20% plus statin, respectively, was 2.90 (2.36 to 3.57) and 2.60 (1.92 to 3.52), and for hypertension plus antihypertensive was 1.33 (1.18 to 1.50). There were no associations with AF, CKD, antiglycaemics or NRT. Detection of several risk factors varied inversely by deprivation. Conclusions HC invitation increased detection of cardiovascular risk factors, but corresponding increases in evidence-based interventions were modest.